Prednisone Use for Influenza
Prednisone and other corticosteroids are NOT recommended for treatment of influenza in patients without severe underlying health conditions and should be avoided, as they are associated with increased mortality, hospital-acquired infections, and prolonged ICU stays. 1, 2, 3
Evidence Against Corticosteroid Use
The most recent and highest-quality evidence consistently demonstrates harm from corticosteroid administration in influenza:
The WHO 2025 clinical practice guidelines provide a strong recommendation AGAINST the use of corticosteroids in severe influenza, based on systematic review evidence showing increased mortality and complications 4
The CDC explicitly advises against using corticosteroids as adjunctive therapy for seasonal influenza treatment, with this recommendation appearing in multiple recent guidelines 1, 3
A 2020 Cochrane systematic review and meta-analysis of 30 studies found corticosteroid therapy was associated with significantly increased mortality (odds ratio 3.90; 95% CI 2.31-6.60) and hospital-acquired infections (odds ratio 2.74; 95% CI 1.51-4.95) 5
A 2018 propensity score-matched study of 1,846 critically ill patients with influenza pneumonia demonstrated that corticosteroid use was independently associated with increased ICU mortality (HR 1.32; 95% CI 1.08-1.60) 6
Recommended Treatment Instead
The appropriate treatment for influenza is antiviral therapy with neuraminidase inhibitors, NOT corticosteroids:
Oseltamivir (Tamiflu) 75 mg twice daily for 5 days is the first-line treatment for patients with confirmed or suspected influenza, particularly those at high risk for complications 7, 8
Treatment should be initiated as soon as possible, ideally within 48 hours of symptom onset, though high-risk and hospitalized patients benefit even when treatment begins after 48 hours 7, 8, 1
Zanamivir is an alternative neuraminidase inhibitor option if oseltamivir is contraindicated or resistance is suspected 7
Limited Exceptions Where Corticosteroids May Be Indicated
Corticosteroids should ONLY be used in influenza patients when indicated for another specific medical condition, not for the influenza itself:
- Treatment of asthma or COPD exacerbation occurring concurrently with influenza 3, 6
- Management of refractory septic shock (following standard sepsis protocols) 3, 6
- Pre-existing conditions requiring ongoing corticosteroid therapy 7
Critical Clinical Pitfalls to Avoid
Do not reflexively prescribe corticosteroids for respiratory symptoms in influenza patients, even if they appear severely ill—this increases mortality risk 2, 3, 5, 6
Do not use corticosteroids to reduce inflammation in influenza pneumonia—observational studies consistently show harm, including increased hospital-acquired pneumonia, longer mechanical ventilation duration, and prolonged ICU stays 2, 5
The harm from corticosteroids appears consistent across different doses, though most studies evaluated relatively high doses (>40 mg methylprednisolone equivalent per day) 5
If a patient is already on chronic corticosteroid therapy for another condition, continue their baseline dose but do not increase it for influenza treatment 7